CT-based whole-body tumor volumetry versus RECIST 1.1: Feasibility and implications for inter-reader variability

Factors That Drive Heterogeneity of Response-to-Treatment of Different Metastatic Deposits Within the Same Patients as Measured by RECIST 1.1 Analyses

(2020) Markus Zimmermann et al.   ACADEMIC RADIOLOGY

Interobserver agreement issues in radiology

(2020) M. Benchoufi et al.   Diagnostic and Interventional Imaging

Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study

(2018) Christiane K. Kuhl et al.   RADIOLOGY

Semi-automatic volumetric measurement of response to chemotherapy in lung cancer patients: How wrong are we using RECIST?

(2017) Vladislav Greenberg et al.   LUNG CANCER

RECIST 1.1—Update and clarification: From the RECIST committee

(2016) Lawrence H. Schwartz et al.   EUROPEAN JOURNAL OF CANCER

Target Lesion Selection

(2014) Sebastian Keil et al.   INVESTIGATIVE RADIOLOGY

Clonal evolution in cancer

(2012) Mel Greaves et al.   NATURE

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER